From Discovery to Clinical Insights – the power of integrating proteomics and genomics data
The value of adding high-plex proteomics to existing genomics data and how proteogenomic approaches accelerate drug target discovery and repurposing
From Discovery to Clinical Insights – the power of integrating proteomics and genomics data
Recent advancements in the field of proteomics have revolutionized the field of multiomics. The SomaScan® Assay from SomaLogic is the only proteomic technology capable of high-plex (measuring over half of the human proteome – 11,000 proteins), high-throughput (rapid processing time and data turnaround), and high sensitivity (measuring both high- and low-abundant proteins) from a single biological sample. Please join us to learn the value of adding high-plex proteomics to existing genomics data and how proteogenomic approaches accelerate drug target discovery and repurposing.
Maik Pietzner, PhD
Berlin Institute of Health at Charité
Universitätsmedizin Berlin, Berlin, Germany
Maik co-leads the group for Computational Medicine at the Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Germany and holds a chair for Health Data Modelling at the Precision Healthcare University Research Institute (PHURI), Queen Mary University of London, UK. He has co-led multiple efforts to associate human genetic variation at scale with intermediate molecular layers, such as proteomics and metabolomics, among various population-based studies that have identified novel pathophysiological pathways and possible treatment targets. His work on protein quantitative trait loci is spearheading the field and he has recently embarked on the integration of electronic health records to systematically augment the space of diagnosis and diseases amendable to in silico prioritisation of novel treatment targets, drug repurposing, or de-risking anchored on rare and common variation in the human genome. His influence on the field is demonstrated by an outstanding track record with publications in Science and the Nature family. Maik obtained his training and PhD in biomathematics at the University of Greifswald graduating with distinction.
From Discovery to Clinical Insights – the power of integrating proteomics and genomics data
A presentation by Maik Pietzner, PhD
More webinars
WebinarEvaluation of precision and correlation for the latest proteomic platforms
The field of proteomics is rapidly advancing, enabling precise measurement of thousands of proteins, particularly those in higher abundance. This webcast will explore significant differences in precision within and across the latest large-scale proteomic platforms and their intercorrelations, based on blind duplicate split assays of the leading modified aptamer-based 11K and antibody proximity ligation-based 5K platforms. Each platform exhibits distinct strengths and limitations, requiring careful consideration prior to implementation in individual studies.
WebinarScaling Proteomics: Balancing Performance and Measuring Enough Proteins
As proteomics platforms have advanced, the number of proteins measured and sample throughput have dramatically increased. However, have sacrifices or trade-offs been necessary to make these gains? To find out, Stephen Williams will analyze how the performance of proteomics platforms has changed over time, comparing precision, sensitivity and specificity as throughput increases.
WebinarBoutique Webinar Aptamers with protein-like side chains as a versatile tool for high-content proteomics
Proteins, encoded in 20,000 genes in humans, do much of the work in biology. Measuring proteins, which change in response to various perturbations and represent targets for almost all drugs, offers insights about the health status of an organism. Since proteins operate in complex networks rather than in isolation, measuring multiple proteins simultaneously offers richer insights compared to single protein measurements.